Basis of Presentation (Details) - Schedule of derivative financial instruments measured at fair value - USD ($)	3 Months Ended	12 Months Ended
Oct. 31, 2021	Jul. 30, 2021
Schedule of derivative financial instruments measured at fair value [Abstract]
Beginning balance		$ 606,123
Derivative from new convertible promissory notes recorded as debt discount		6,820,108
Derivative liability resolved to additional paid in capital due to debt conversion		(588,097)
Derivative loss (Loss)	(4,433,880)	9,935,249
Ending balance	$ 12,339,503	$ 16,773,383

Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 25
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Name:	us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration